Position in PRGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,725,282
New position
Shares Held
719,300
first reported quarter
Ownership
0.520%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in PRGO
reported options exposure · as of Mar 31, 2026CallValue
$1,074,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CastleKnight Management LP holds $18,349,741 across 3 Drug Manufacturers - Specialty & Generic names. PRGO ranks #1 (42.1% of the industry book) .
All Filings in PRGO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,074,000 | 100,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $7,725,282 | 719,300 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||